Green Cross Holdings Corporation (KRX: 005250)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,300
-50 (-0.33%)
Oct 8, 2024, 3:30 PM KST
8.90%
Market Cap 720.98B
Revenue (ttm) 2.11T
Net Income (ttm) -75.26B
Shares Out 45.40M
EPS (ttm) -1,657.58
PE Ratio n/a
Forward PE n/a
Dividend 300.00 (1.90%)
Ex-Dividend Date n/a
Volume 48,644
Open 15,280
Previous Close 15,350
Day's Range 15,170 - 15,630
52-Week Range 12,940 - 18,490
Beta 0.85
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1967
Employees 154
Stock Exchange Korea Stock Exchange
Ticker Symbol 005250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.